Tag Archives: Metabolic Disease

Data on VIVUS’ Qnexa to be Featured at World Congress Highlighting Metabolic Disease and Related Disorders

Posted on May 13, 2010 by

MOUNTAIN VIEW, Calif., May 13 /PRNewswire-FirstCall/ — VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa®, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) in Prague, Czech Republic. Timothy Garvey, … Continue reading →

Posted in News | Tagged hypertension, Metabolic Disease, obesity, Qnexa, Weight loss | Leave a comment